Lonza’s stem cell production insight a boon to innovation and business – BioPharma-Reporter.com
BioPharma-Reporter.com |
Lonza's stem cell production insight a boon to innovation and business
BioPharma-Reporter.com So when Swiss-based contract manufacturing organisation (CMO) Lonza published a paper in the Stem Cell Report Journal last week giving industry a comprehensive insight into the cGMP manufacture of human induced pluripotent stem cells (IPSCs), we … |
